STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BSI; BACTEREMIA)
Clinical trials for STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BSI; BACTEREMIA) explained in plain language.
Never miss a new study
Get alerted when new STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BSI; BACTEREMIA) trials appear
Sign up with your email to follow new studies for STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BSI; BACTEREMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to beat staph blood infections
Disease control Recruiting nowThis study tests whether adding the antibiotic linezolid to standard treatment improves outcomes for people with Staphylococcus aureus bloodstream infections. About 606 hospitalized adults will receive either linezolid or a placebo for five days. The goal is to see if the combina…
Matched conditions: STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BSI; BACTEREMIA)
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Which antibiotic wins? new study tests penicillin against standard care for staph blood infection
Disease control Recruiting nowThis study tests whether penicillin works better than the usual antibiotic cloxacillin for people with a Staph blood infection that is sensitive to penicillin. About 420 adults will be randomly assigned to one of the two treatments. The main goal is to see who survives 90 days wi…
Matched conditions: STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BSI; BACTEREMIA)
Phase: PHASE4 • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC